UCB SA
Technical analysis of UCB SA (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is UCB SA
UCB SA is a biopharmaceutical company that develops and markets products for the treatment of neurology and immunology diseases. The company's portfolio includes medicines for epilepsy, rheumatological diseases, neurological disorders, allergies and other conditions, as well as contract manufacturing solutions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the UCB.BR analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about UCB SA
How is UCB SA analysed technically?
Technical analysis of UCB SA is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for UCB SA?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to UCB SA?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to UCB SA it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.